Company intelligence / Profile preview

INU Energy

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Inu is a longevity-focused biotechnology and consumer health company dedicated to optimizing cellular energy and mitochondrial function. The company develops science-backed products designed to enhance mitochondrial health, primarily through the modulation of NAD+ levels and cellular repair mechanisms. Its flagship product is a daily cellular energy drink formulated with a proprietary blend of ingredients aimed at improving metabolic efficiency and physical performance. By bridging the gap between advanced biotechnology and consumer wellness, Inu seeks to provide accessible solutions for healthy aging and sustained vitality.

Therapeutic areas: Rare DiseasesOtherMetabolic Disorders
Modalities: Small moleculeNutraceutical
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on INU Energy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on INU Energy.

Explore the full profile